IRONWOOD PHARMACEUTICALS INC's ticker is and the CUSIP is 46333XAD0. A total of 20 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $125,000 | -1.6% | 123,000 | 0.0% | 0.00% | – |
| Q4 2021 | $127,000 | +135.2% | 123,000 | +146.0% | 0.00% | – |
| Q3 2021 | $54,000 | 0.0% | 50,000 | 0.0% | 0.00% | – |
| Q2 2021 | $54,000 | 0.0% | 50,000 | 0.0% | 0.00% | – |
| Q1 2021 | $54,000 | 0.0% | 50,000 | 0.0% | 0.00% | – |
| Q4 2020 | $54,000 | +3.8% | 50,000 | 0.0% | 0.00% | – |
| Q3 2020 | $52,000 | 0.0% | 50,000 | 0.0% | 0.00% | – |
| Q2 2020 | $52,000 | -1.9% | 50,000 | 0.0% | 0.00% | – |
| Q1 2020 | $53,000 | -8.6% | 50,000 | 0.0% | 0.00% | – |
| Q4 2019 | $58,000 | +16.0% | 50,000 | 0.0% | 0.00% | – |
| Q3 2019 | $50,000 | -5.7% | 50,000 | 0.0% | 0.00% | – |
| Q2 2019 | $53,000 | -49.5% | 50,000 | -38.3% | 0.00% | – |
| Q3 2018 | $105,000 | -1.9% | 81,000 | 0.0% | 0.00% | – |
| Q2 2018 | $107,000 | +723.1% | 81,000 | +636.4% | 0.00% | – |
| Q1 2018 | $13,000 | -99.3% | 11,000 | -99.4% | 0.00% | -100.0% |
| Q4 2016 | $1,998,000 | – | 1,746,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| K2 PRINCIPAL FUND, L.P. | 9,000 | $9,953,000 | 0.83% |
| CSS LLC/IL | 10,119,000 | $11,031,000 | 0.46% |
| DeepCurrents Investment Group LLC | 13,556,000 | $14,917,000 | 0.45% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 10,000,000 | $11,014,000 | 0.24% |
| WOLVERINE ASSET MANAGEMENT LLC | 28,592,000 | $31,218,000 | 0.24% |
| HBK INVESTMENTS L P | 14,616,000 | $15,971,000 | 0.06% |
| PALISADE CAPITAL MANAGEMENT, LP | 2,127,000 | $2,334,000 | 0.05% |
| Verition Fund Management LLC | 3,942,000 | $4,304,000 | 0.04% |
| LAZARD ASSET MANAGEMENT LLC | 10,037,000 | $10,959,000 | 0.01% |
| Calamos Advisors LLC | 2,423,000 | $2,648,000 | 0.01% |